🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Margaret V. Ragni

University of Pittsburgh

ORCID: 0000-0002-7830-5379

Also affiliated with University of Pittsburgh Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial”.

Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial

The Lancet Haematology(2023)10.1016/s2352-3026(23)00119-9
N/A
1.4DataRank · unranked
38 citations

Scott D. Rothenberger, Robert Feldman, Danielle Nance, Andrew D. Leavitt, Lynn Malec +23 more

Intravascular hemolysis triggers ADP-mediated generation of platelet-rich thrombi in precapillary pulmonary arterioles

JCI Insight(2020)10.1172/jci.insight.139437
N/A
0.396DataRank · unranked
13 citations

Ravi Vats, Margaret F. Bennewitz, Egemen Tütüncüoğlu, Simon C. Watkins, Margaret V. Ragni +4 more

Phase II Prospective Open-Label Trial of Recombinant Interleukin-11 in DDAVP-Unresponsive Von Willebrand Disease and Mild or Moderate Hemophilia A

(2020)10.17615/t44h-ek26
N/A
0DataRank · unranked
0 citations

Margaret V. Ragni, Timothy C. Nichols, Elizabeth P. Merricks, Anila Murshed, Enrico M. Novelli +1 more

Phase II prospective open-label trial of recombinant interleukin-11 in women with mild von Willebrand disease and refractory menorrhagia

UNC Libraries(2020)10.17615/068j-6c95
N/A
0DataRank · unranked
0 citations

Mark Kloos, Margaret V. Ragni, Timothy C. Nichols, Rachel C. Jankowitz, Elizabeth P. Merricks +1 more

Quality of periprocedural care in patients with von Willebrand disease

Haemophilia(2021)10.1111/hae.14389
N/A
0DataRank · unranked
3 citations

Marnie Bertolet, Jun Zhang, Margaret V. Ragni, Craig D. Seaman

Defenestrated endothelium delays liver-directed gene transfer in hemophilia A mice

Blood Advances(2022)10.1182/bloodadvances.2021006388
N/A
0DataRank · unranked
6 citations

Eun-Mi Ju, Shweta Gudapati, Ravi Vats, Sanya Arshad, Rikesh K. Dubey +12 more

Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B

Molecular Therapy(2020)10.1016/j.ymthe.2020.06.001
N/A
0DataRank · unranked
210 citations

Margaret V. Ragni, John E.J. Rasko, Leslie Raffini, Benjamin J. Samelson‐Jones, Margareth C. Ozelo +10 more

Innovations in RNA therapy for hemophilia

Blood(2023)10.1182/blood.2022018661
N/A
0DataRank · unranked
14 citations

Stephen Y. Chan, Margaret V. Ragni

Rituximab for treatment of inhibitors in haemophilia A: A Phase II Study

UNC Libraries(2020)10.17615/cxmv-hp88
N/A
0DataRank · unranked
4 citations

Marcela Torres, Leslie Raffini, Kapil Saxena, Keith R. McCrae, Cindy Leissinger +14 more